Max Robotics — Global Service Robot Directory + US Certification

About

Fabrice Muscari is a leading figure in hepatopancreatobiliary and digestive surgery, with a focused expertise in minimally invasive pancreatic procedures. His research centers on improving surgical outcomes by identifying risk factors and developing predictive tools for complex operations. A major contribution is the development of a Conversion Risk Score (CRS) for Minimally Invasive Left Pancreatectomy (MILP), a procedure where conversion to open surgery occurs in 15-30% of cases. His seminal 2025 work, cited 4 times, rigorously analyzes risk factors for conversion and its association with severe postoperative complications, providing surgeons with a practical framework for preoperative planning and patient counseling. This work directly addresses a critical gap in surgical safety, aiming to reduce morbidity and enhance patient recovery. Dr. Muscari’s research is instrumental in advancing the precision and safety of minimally invasive surgery, offering evidence-based strategies that guide clinical decision-making and improve outcomes for patients undergoing complex pancreatic resections.